153 related articles for article (PubMed ID: 21609523)
21. Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.
Freeman M; Clark DJ; Andrianopoulos N; Duffy SJ; Lim HS; Brennan A; Charter K; Shaw J; Horrigan M; Ajani AE; Sebastian M; Reid CM; Farouque HM;
Catheter Cardiovasc Interv; 2009 May; 73(6):763-8. PubMed ID: 19309731
[TBL] [Abstract][Full Text] [Related]
22. Treatment of left main coronary trifurcation lesions with the paclitaxel drug-eluting stent: mid-term outcomes from a tertiary medical center.
Shammas NW; Shammas GA; Jerin M; Parikh A; Coin K; Dippel E; Sharis P; Robken J
J Invasive Cardiol; 2009 Jul; 21(7):321-5. PubMed ID: 19571341
[TBL] [Abstract][Full Text] [Related]
23. Coronary artery bypass surgery is superior to percutaneous coronary intervention with drug-eluting stents for patients with chronic renal failure on hemodialysis.
Sunagawa G; Komiya T; Tamura N; Sakaguchi G; Kobayashi T; Murashita T
Ann Thorac Surg; 2010 Jun; 89(6):1896-900; discussion 1900. PubMed ID: 20494045
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
Qasim A; Cosgrave J; Latib A; Colombo A
Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
[TBL] [Abstract][Full Text] [Related]
25. Transradial percutaneous coronary intervention in acute ST elevation myocardial infarction and high-risk patients: experience in a single centre without cardiothoracic surgical backup.
Chow J; Tan CH; Ong SH; Goh YS; Gan HW; Tan VH; Chai SC
Singapore Med J; 2011 Apr; 52(4):257-62. PubMed ID: 21552786
[TBL] [Abstract][Full Text] [Related]
26. Transradial primary angioplasty and stenting in Indian patients with acute myocardial infarction: acute results and 6-month follow-up.
Ranjan A; Patel TM; Shah SC; Malhotra H; Patel R; Vayada N; Pothiwala R; Fonseca K; Tanwar NS
Indian Heart J; 2005; 57(6):681-7. PubMed ID: 16521638
[TBL] [Abstract][Full Text] [Related]
27. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
[TBL] [Abstract][Full Text] [Related]
28. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
[TBL] [Abstract][Full Text] [Related]
29. Impact of drug-eluting stents on outcomes of patients with end-stage renal disease undergoing percutaneous coronary revascularization.
Das P; Moliterno DJ; Charnigo R; Mukherjee D; Steinhubl SR; Sneed JD; Booth DC; Ziada KM
J Invasive Cardiol; 2006 Sep; 18(9):405-8. PubMed ID: 16954577
[TBL] [Abstract][Full Text] [Related]
30. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL;
Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853
[TBL] [Abstract][Full Text] [Related]
31. One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.
Varani E; Balducelli M; Vecchi G; Aquilina M; Maresta A
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):596-601. PubMed ID: 17667030
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions.
Han YL; Zhang J; Li Y; Wang SL; Jing QM; Yi XH; Ma YY; Luan B; Wang G; Wang B
Chin Med J (Engl); 2009 Mar; 122(6):643-7. PubMed ID: 19323927
[TBL] [Abstract][Full Text] [Related]
34. Randomized comparison of radial versus femoral approach for patients with STEMI undergoing early PCI following intravenous thrombolysis.
Wang YB; Fu XH; Wang XC; Gu XS; Zhao YJ; Hao GZ; Jiang YF; Li SQ; Wu WL; Fan WZ
J Invasive Cardiol; 2012 Aug; 24(8):412-6. PubMed ID: 22865313
[TBL] [Abstract][Full Text] [Related]
35. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.
Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445
[TBL] [Abstract][Full Text] [Related]
36. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
[TBL] [Abstract][Full Text] [Related]
37. Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE Registry).
Caggegi A; Capodanno D; Capranzano P; Chisari A; Ministeri M; Mangiameli A; Ronsivalle G; Ricca G; Barrano G; Monaco S; Di Salvo ME; Tamburino C
Am J Cardiol; 2011 Aug; 108(3):355-9. PubMed ID: 21545992
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
[TBL] [Abstract][Full Text] [Related]
39. Comparison of drug-eluting stents with bare metal stents implantation for the treatment of acute ST-elevation myocardial infarction: 2-year clinical outcomes from single-center registry.
Li Y; Han YL; Zhang QY; Guan SY; Wang XZ; Jing QM; Ma YY; Wang G; Wang B; Deng J
Chin Med J (Engl); 2011 Mar; 124(6):825-30. PubMed ID: 21518587
[TBL] [Abstract][Full Text] [Related]
40. Immediate results of percutaneous coronary intervention for unprotected left main coronary artery stenoses: transradial versus transfemoral approach.
Hsueh SK; Hsieh YK; Wu CJ; Fang CY; Youssef AA; Chen CJ; Chen SM; Yang CH; Yip HK; Chen MC; Fu M; Cheng CI
Chang Gung Med J; 2008; 31(2):190-200. PubMed ID: 18567420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]